BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18794660)

  • 21. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
    Fenton WS; Chavez MR
    Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676
    [No Abstract]   [Full Text] [Related]  

  • 23. [Challenges in nutrition-based treatment for weight control in adolescents suffering from schizophrenia].
    Shani M; Levi M; Zalsman G
    Harefuah; 2008 Nov; 147(11):901-5, 939. PubMed ID: 19264012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients.
    Sentissi O; Viala A; Bourdel MC; Kaminski F; Bellisle F; OliƩ JP; Poirier MF
    Int Clin Psychopharmacol; 2009 Sep; 24(5):257-64. PubMed ID: 19606055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical antipsychotics and weight gain.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When the heart and the mind collide: cardiovascular risk factors and antipsychotic use in the schizophrenic population.
    Halpert S; McFarlane SI
    J Cardiometab Syndr; 2009; 4(1):1-5. PubMed ID: 19245509
    [No Abstract]   [Full Text] [Related]  

  • 27. Lurasidone for schizophrenia.
    Drug Ther Bull; 2015 Mar; 53(3):30-2. PubMed ID: 25765597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment with atypical antipsychotics and risk of weight gain.
    Stip E; Anselmo K; Wolfe M; Lessard C; Landry P
    Drug Saf; 2006; 29(6):550-2; author reply 552. PubMed ID: 16752937
    [No Abstract]   [Full Text] [Related]  

  • 29. Weighing in: emergent diabetes mellitus and second-generation antipsychotics.
    Dufresne RL
    Ann Pharmacother; 2007 Oct; 41(10):1725-7. PubMed ID: 17785611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep apnea associated with antipsychotic-induced obesity.
    Wirshing DA; Pierre JM; Wirshing WC
    J Clin Psychiatry; 2002 Apr; 63(4):369-70. PubMed ID: 12000215
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of clinical body composition methods in people taking weight-inducing atypical antipsychotic medications.
    Sharpe JK; Byrne NM; Stedman TJ; Hills AP
    Asia Pac J Clin Nutr; 2008; 17(4):573-9. PubMed ID: 19114392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizophrenia, weight gain and atypical antipsychotics.
    Brown S
    Br J Psychiatry; 2006 Feb; 188():191-2. PubMed ID: 16449712
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients.
    Thirthalli J; Venkatesh BK; Kishorekumar KV; Arunachala U; Venkatasubramanian G; Subbakrishna DK; Gangadhar BN
    Acta Psychiatr Scand; 2009 Mar; 119(3):209-17. PubMed ID: 19053968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.
    Volavka J; Citrome L
    Expert Opin Pharmacother; 2009 Aug; 10(12):1917-28. PubMed ID: 19558339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antipsychotic agents and weight gain].
    Raaska K
    Duodecim; 2002; 118(2):157-62. PubMed ID: 12229110
    [No Abstract]   [Full Text] [Related]  

  • 36. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
    Leucht S; Kissling W; Davis JM
    Psychol Med; 2009 Oct; 39(10):1591-602. PubMed ID: 19335931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atypical antipsychotic induced weight gain and metabolic disorders].
    Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
    Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weight gain, antipsychotic drug treatment and pharmacogenomics.
    Reynolds GP
    Pharmacogenomics; 2002 Sep; 3(5):567-70. PubMed ID: 12223042
    [No Abstract]   [Full Text] [Related]  

  • 40. Is antipsychotic drug--induced weight gain associated with a favorable clinical response?
    Lamberti JS
    J Clin Psychiatry; 2000 Sep; 61(9):678. PubMed ID: 11030490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.